Application 208124
- Type
- ANDA
- Sponsor
- LUPIN ATLANTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DESOXIMETASONE | DESOXIMETASONE | SPRAY;TOPICAL | 0.25% | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68180-944 | Desoximetasone | Desoximetasone | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-944 | Desoximetasone | Desoximetasone | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-944 | Desoximetasone | Desoximetasone | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-944 | Desoximetasone | Desoximetasone | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-944 | Desoximetasone | Desoximetasone | Lupin Pharmaceuticals, Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 53616 | ORIG | 2018-04-05 |